Physician profile
Christopher D'Angelo
NPI 1982099776
$5,688.76
in general payments reported to CMS, 2019-2025
38 companies · $907 in 2025
The $907 reported for 2025 was more than what 76% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $557 · 2021: $366 · 2022: $108 · 2023: $973 · 2024: $1,678 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100 · Travel and Lodging: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,099.67 |
| Travel and Lodging | $458.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,244.46 | 2019-2024 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $1,057.54 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Getinge USA Sales, LLC | $458.24 | 2025 | Vasoview Hemopro 2 |
| Regeneron Healthcare Solutions, INC. | $303.13 | 2022-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.05 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mallinckrodt Enterprises LLC | $270.87 | 2019 | |
| Mylan Specialty L.P. | $255.64 | 2023-2024 | Yupelri |
| Insmed, INC. | $243.59 | 2019-2025 | Arikayce |
| Pulmonx Corporation | $136.82 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $135.14 | 2019 | |
| Amgen INC. | $108.21 | 2023-2024 | Tezspire, Otezla, Repatha |
| Corcept Therapeutics | $91.16 | 2024-2025 | Korlym |
| Lilly USA, LLC | $89.01 | 2023-2024 | Mounjaro |
| Genzyme Corporation | $80.73 | 2024 | |
| Verona Pharma, INC. | $78.41 | 2025 | Ohtuvayre |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher D'Angelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.